EHJ Editor-in-Chief
@ehj_ed
Followers
37K
Following
702
Media
3K
Statuses
3K
Official twitter account of the European Heart Journal Editor-in-Chief. Tweets by Prof. Filippo Crea and his team. #EHJ.
Rome, Italy
Joined January 2020
Non-amyloid specific treatment for transthyretin cardiac amyloidosis: a clinical consensus statement of the ESC Heart Failure Association just published in #EHJ
@escardio @ESC_Journals #amyloidosis
https://t.co/0UxCjhTivy
0
2
3
Stable angina in young women. A State-of-the-Art review exploring pathophysiological mechanisms, risk factors and potential treatment options. Read more in #EHJ
@escardio @ESC_Journals #angina
https://t.co/Yh9Nfig3T5
3
35
115
We just published the Great debate: fire-and-forget beats personalized lipid-lowering treatment https://t.co/3enK5cA1Li
@ProfKausikRay @EugeniaGianos @TKDsosyal @DrMarthaGulati @society_eas @MeralKayikcoglu
academic.oup.com
Atherosclerotic vascular disease (ASCVD) remains a leading cause of morbidity and mortality, yet effective risk factor management offers the potential to s
1
22
78
Transthyretin amyloid cardiomyopathy is a progressive disorder marked by amyloid deposition in the heart, ultimately impairing cardiac function. Read the new state of the art review. https://t.co/AQWaLlr2nx
#HF #heartfailure #amyloidosis #cardiotwitter, @ESC_Journals, @escardio
1
12
50
The key-steps for a modern management of carotid atherosclerotic disease summarized in 10 points! https://t.co/dpOvYkoDtf
#CEA #CAS #carotid #cardiotwitter, @ESC_Journals, @escardio
1
39
112
Safety of drug-coated devices for femoropopliteal artery intervention: long-term outcomes of the SAFE-PAD study published. https://t.co/3vRJjK6daD
#DES #DCB #DEB #SFA #PAD #cardiotwitter, @ESC_Journals, @escardio
0
4
25
EHJ issue 46 - 37 is online: https://t.co/7LRvNvkb5Z Enjoy this Focus Issue on digital health, which spans topics from AI-based preclinical diagnosis of amyloidosis to its applications in pharmacotherapy. @escardio @ESC_Journals #EHJ #cardiotwitte
1
5
27
Transient increases in anticholinergic burden might raise out-of-hospital cardiac arrest risk. New data published. https://t.co/5H9FL9Jig2
#arrhythmias #cardiacarrest #cardiotwitter, @ESC_Journals, @escardio
1
10
31
Clinical impact of antihypertensive treatment in young adults and cardiovascular risk. https://t.co/NFHpJSiiw2
#hypertension #young #cardiotwitter, @ESC_Journals, @escardio
0
5
13
Atrial fibrillation-related atrial remodelling is consider to pontantially be influenced by sex. New electroanatomic mapping and biopsy study. https://t.co/pwaEGdinHa
#AF, #atrialfibrillation #biopsy #arrhythmias #cardiotwitter @ESC_Journals @escardio
0
19
60
Understanding how blood vessel cells turn into fibrosis-promoting cells may open new ways to prevent atrial fibrillation complications. Read more in #EHJ. https://t.co/bCFoC0R8KA
#AF #endothelial #cardiotwitter #AtrialFibrillation #CardiacFibrosis #TranslationalMedicine
0
5
17
Hidden culprit in atrial fibrillation? Biopsy reveals atrial amyloidosis—more common with age and structural heart changes. Read more in #EHJ. https://t.co/jWe6DKBMmf
#cardiotwitter #AtrialFibrillation #CardiacAmyloidosis #AgingHeart @ESC_Journals @escardio
0
11
26
Surgical myectomy saves lives in obstructive hypertrophic cardiomyopathy, but what happens in low-volume, real-world centers? Read the latest editorial in #EHJ. https://t.co/QKsGinmJvd
#HCM #myectomy #cardiotwitter #CardiacSurgery #SurgicalOutcomes
@ESC_Journals @ESCardio
0
15
71
EHJ Dialogue on multiagonist strategies targeting obesity to reduce cardiovascular risk: the REDEFINE 1 trial
0
1
6
🚨 Join us today at 17:00 CEST for our next EHJ Dialogue! 🫀Profs. Timothy Garvey and Tricia Tan review the REDEFINE 1 trial and the potential of semaglutide and cagrilintide for weight reduction. Moderated by Weekly Journal Scan editors Profs. Carlo Patrono and Giovanna
1
2
7
Combination lipid-lowering strategies after acute coronary syndrome: reconsidering cholesterol targets. Read more in EHJ. @ESCardio @ESC_Journals #Cardiology #LipidLowering #Cholesterol #AcuteCoronarySyndrome #CardiovascularHealth #HeartResearch #LDLC
0
6
31
A newly identified enhancer variant near KCNB1 drives familial ST-depression syndrome, opening a novel genetic pathway to arrhythmia and dysfunction. Read more in #EHJ. https://t.co/sisud4gV7o
#Cardiomyopathy #gene #cardiotwitter @ESC_Journals @escardio
0
6
34
Gene editing opens new doors for familial hypercholesterolemia and elevated lipoprotein a, beyond traditional lipid-lowering therapies. Read more in #EHJ. https://t.co/BV6AQ6zKQk
#lipoprotein #cholesterol #gene #cardiotwitter @ESC_Journals @escardio
3
24
108
After thrombolysis in minor stroke, starting antiplatelets earlier could prevent deterioration and improve outcomes. Read the result of EAST trial in #EHJ. https://t.co/IisfZ3oBlB
#stroke #antiplatelet #cardiotwitter @ESC_Journals @escardio
1
8
26
Long QT syndrome in the young isn’t just a number on the ECG, risk depends on genetics, QTc length, and treatment. Early recognition and tailored care save lives. Read more in #EHJ. https://t.co/lNgBnn65R8
#longQT #suddendeath #cardiotwitter @ESC_Journals @escardio
1
10
53